The risk that transactions such as advertising production, product and raw-material sales, and loans involving specific related parties, including SBCメディカルグループ, may lead to unfair transaction terms or an increase in receivables because the rationale and pricing of the transactions, and governance over related-party transactions, are not functioning effectively.